NAMS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

NewAmsterdam Pharma Company NV (NAMS) Moving Averages Convergence Divergence (MACD) indicator is 0.252, suggesting NAMS is Strong Buy.

NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 32.044, while NewAmsterdam Pharma Company NV (NAMS) share price is $38.73, making it Buy.

NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 32.255, while NewAmsterdam Pharma Company NV (NAMS) share price is $38.73, making it Buy.

Technical Analysis for NAMS

Technical Sentiment Analysis for NewAmsterdam Pharma Company NV (NAMS) As of 2026-05-08, NewAmsterdam Pharma Company NV (NAMS) is exhibiting a Strong Buy technical sentiment. Our proprietary analysis, which aggregates 18 technical signals, shows that 14 indicators are flashing buy, while 4 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for NAMS stands at 70.641, which suggests a Sell condition. Meanwhile, the MACD (12, 26) indicator is at 0.252, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 72.425 and the Commodity Channel Index (CCI) at 177.133 further confirm a 9.01 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, NAMS is trading above its 60-day moving average of $32.255 and above its 200-day long-term moving average of $31.946. Key price levels to watch include the immediate resistance at $38.755 and strong support at $25.435. A break above $38.755 could signal a bull continuation, while falling below $25.435 may test the next Fibonacci floor at $19.982.

NewAmsterdam Pharma Company NV (NAMS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	12.115	19.982	25.435	33.302	38.755	46.622	52.075
Fibonacci	19.982	25.071	28.214	33.302	38.391	41.534	46.622

NewAmsterdam Pharma Company NV (NAMS) Technical Indicators

2026-05-08

Name	Value
RSI_14	70.641
STOCHk_14_3_3	72.425
STOCHd_14_3_3	52.891
CCI_20	177.133
AO_5_34	0.0616
MOM_10	9.01
MACD_12_26_9	0.252

NewAmsterdam Pharma Company NV (NAMS) Relative Strength Index (RSI) is 70.641, creating a Sell signal.

NewAmsterdam Pharma Company NV (NAMS) Stochastic Oscillator is 72.425, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Stochastic RSI is 52.891, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Commodity Channel Index (CCI) is 177.133, creating a Sell signal.

NewAmsterdam Pharma Company NV (NAMS) Awesome Oscillator is 0.0616, creating a Buy signal.

NewAmsterdam Pharma Company NV (NAMS) Momentum is 9.01, creating a Buy signal.

NewAmsterdam Pharma Company NV (NAMS) MACD is 0.252, creating a Buy signal.

NewAmsterdam Pharma Company NV (NAMS) Moving Average

2026-05-08

Period	Simple	Signal
MA_5	32.856	Buy
MA_10	30.887	Buy
MA_20	32.044	Buy
MA_60	32.255	Buy
MA_200	31.946	Buy
MA_250	29.483	Buy

NewAmsterdam Pharma Company NV (NAMS) 5-Day simple moving average is 32.856, while NewAmsterdam Pharma Company NV (NAMS) share price is $38.73, making it a Buy.

NewAmsterdam Pharma Company NV (NAMS) 10-Day simple moving average is 30.887, while NewAmsterdam Pharma Company NV (NAMS) share price is $38.73, making it a Buy.

NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 32.044, while NewAmsterdam Pharma Company NV (NAMS) share price is $38.73, making it a Buy.

NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 32.255, while NewAmsterdam Pharma Company NV (NAMS) share price is $38.73, making it a Buy.

NewAmsterdam Pharma Company NV (NAMS) 200-Day simple moving average is 31.946, while NewAmsterdam Pharma Company NV (NAMS) share price is $38.73, making it a Buy.

NewAmsterdam Pharma Company NV (NAMS) 250-Day simple moving average is 29.483, while NewAmsterdam Pharma Company NV (NAMS) share price is $38.73, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for NAMS?

The overall technical consensus for NewAmsterdam Pharma Company NV (NAMS) is currently Strong Buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 8 buy signals and 4 sell signals.

What are the key support and resistance levels for NewAmsterdam Pharma Company NV (NAMS) today?

Based on pivot point calculations, NewAmsterdam Pharma Company NV (NAMS) has an immediate support level at 25.435 and a major resistance level at 38.755. Traders also monitor the pivot point at 33.302 to determine the intraday trend direction.

Is NewAmsterdam Pharma Company NV (NAMS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for NewAmsterdam Pharma Company NV (NAMS) is currently 70.641. This indicates that the stock is in overbought territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for NewAmsterdam Pharma Company NV (NAMS)?

NewAmsterdam Pharma Company NV (NAMS) Moving Averages Convergence Divergence (MACD) indicator is 0.252, suggesting NAMS is Strong Buy. This indicator helps identify potential trend reversals or momentum shifts for NewAmsterdam Pharma Company NV.

How is NewAmsterdam Pharma Company NV (NAMS) performing relative to its 200-day moving average?

NewAmsterdam Pharma Company NV (NAMS) is currently trading at $38.73, which is above its 200-day simple moving average of 31.946. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.